JANX icon

Janux Therapeutics
JANX

Overview Fund Activity

30 hedge funds and large institutions have $614M invested in Janux Therapeutics in 2021 Q2 according to their latest regulatory filings, with 30 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

Holders
30
Holders Change
+30
Holders Change %
–
% of All Funds
0.52%
Holding in Top 10
3
Holding in Top 10 Change
+3
Holding in Top 10 Change %
%
% of All Funds
0.05%
New
30
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
RCM
1
RA Capital Management
Massachusetts
$216M
2
O
2
OrbiMed
New York
$86.5M
3
Janus Henderson Group
3
Janus Henderson Group
United Kingdom
$64.5M
4
Citadel Advisors
4
Citadel Advisors
Florida
$46.2M
5
Fidelity Investments
5
Fidelity Investments
Massachusetts
$46M

Top Sellers

No sellers this quarter
Name Market Value Shares Shares
Change 		Shares
Change %
Royal Bank of Canada
26
Royal Bank of Canada
Ontario, Canada
$32K 1,300 +1,300 New
JPMorgan Chase & Co
27
JPMorgan Chase & Co
New York
$16K 646 +646 New
UBS Group
28
UBS Group
Switzerland
$9K 353 +353 New
Morgan Stanley
29
Morgan Stanley
New York
$2K 100 +100 New
CFGS
30
Concourse Financial Group Securities
Alabama
– – – –
US Bancorp
31
US Bancorp
Minnesota
$0 7 +7 New
1
2